ClinicalTrials.gov
public full text
Public Domain
Neuroinflammation in Patients With OCD
The goal of this study is to examine whether measurements of inflammation from brain scanning and blood tests can predict how much benefit patients with obsessive-compulsive disorder (OCD) will have from treatment with an anti-inflammatory medication, celecoxib, when adding to ongoing medication-based treatment for OCD.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder#980181
- Cognitive Training in Obsessive Compulsive Disorder#1124803
- Family Based Treatment of Early Childhood Obsessive Compulsive Disorder#911088
- Flecainide in Treating Patients With Chronic Neuropathic Pain#879516
- Psychological Perspectives Of Obsessive-Compulsive Disorder#764647
Record · ID 1172533
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive